|
|
|
|
|
|
By Jyotsna Jajula, Research Assistant, Wayne State University | RNA therapeutics are reshaping medicine, but instability and limited organ targeting still pose challenges. Discover how next-gen lipid nanoparticles and smart delivery systems are advancing RNA precision. | |
|
|
|
We all know that plasmid quality is foundational in dictating the quality of the final mRNA drug substance. In this clip homing in on upstream process considerations, speakers Stu Sundseth (Tune Therapeutics), Marc Wolfgang (Sail Biomedicines), and Christian Dohmen (Ethris) outline some of the most important CQAs for plasmids and the impact they can have on the resulting quality of the mRNA drug substance for linear mRNA. |
|
|
|
By Ben Comer, Chief Editor, Life Science Leader | Part one of a two-part series on FDA Commissioner Martin Makary, M.D.'s comments at the Gailen Forum in New York City on October 30, 2025. | |
|
|
|
|
|
|
|
|
|
| Understanding The Intricacies Of qMSI | Infographic | Aliri Bioanalysis | Explore quantitative mass spectrometry imaging (QMSI) and leading spatial bioanalysis and biology services that offer one-on-one support throughout your drug development process. |
|
|
|
|
| Webinar: The mRNA Journey: From Design to LNP-Ready Molecules for Research | Discover a validated, end-to-end workflow for producing high-quality IVT mRNA for preclinical research. This Agilent webinar covers every step—from sequence design and PCR-based DNA template preparation to transcription, lipid nanoparticle formulation, and QC testing with Agilent TapeStation and Fragment Analyzer—enabling fast, reliable, small-scale mRNA production for vaccines, protein expression, and gene or cell therapy. Click here to learn more. |
|
|
|
|
|
|
|
|
|
|
|
.png){kind=logo}
